false
0001708341
0001708341
2026-11-18
2026-11-18
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (date of earliest event reported):
November 18, 2026
| ALL
IN FUTURETECH ALLIANCE, INC. |
| (Exact
name of Registrant as specified in its charter) |
| Delaware |
|
001-38226 |
|
82-1659427 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File No.) |
|
(IRS Employer
Identification No.) |
745 Fifth Avenue, Suite 500
New York, New York 10151
(Address of principal executive offices, including
zip code)
(646) 768-4240
(Registrant’s telephone number, including
area code)
Not Applicable
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
| |
|
| ☒ |
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title
of Each Class |
|
Trading
Symbol(s) |
|
Name
of Each Exchange on Which Registered |
| Common Stock, par value
$0.0001 per share |
|
AIFA |
|
NASDAQ |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter):
Emerging growth company ☐
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
Stock Purchase Agreement
On November 18, 2026, All In FutureTech Alliance,
Inc. (the “Company” or “AIFA”) entered into a Stock Purchase Agreement (the “Purchase Agreement”)
with Li Shanglong (also known as Shanglong Li, the “Seller”) and Little Vault Inc., a California corporation (“Little
Vault”). The Seller is the Company’s chairman, a director and, effective November 19, 2026, its Chief Executive Officer, and
owns all of the outstanding equity of Little Vault. Under the Purchase Agreement, the Company agreed to acquire all of the outstanding
equity of Little Vault from the Seller (the “Acquisition”). The Purchase Agreement became effective upon execution by all
parties. The Acquisition remains subject to closing conditions and has not been completed.
Little Vault operates a multi-channel network
and personal intellectual property commercialization business involving content creators, key opinion leaders, celebrities, professionals
and experts. Its activities include content planning and production, account operation, audience development, courses and training, advertising
and brand cooperation, livestreaming, e-commerce, paid content and platform revenue sharing.
Consideration and transfer restrictions
The agreed equity valuation and purchase price
are $8 million, payable entirely through the issuance to the Seller at closing of 1,280,000 shares of the Company’s common stock,
par value $0.0001 per share (the “Consideration Shares”), at an agreed reference price of $6.25 per share. The Consideration
Shares represent approximately 19.9% of the Company’s issued and outstanding common stock as of November 18, 2026, before giving
effect to the issuance. All Consideration Shares will be issued at closing; none will be issued in installments. The share number and
reference price are subject to proportionate adjustment for stock splits and similar recapitalizations, but not to a market-price reset.
At closing, all Consideration Shares will be issued
in book-entry form into a restricted escrow or transfer-agent hold account in the Seller’s name. The Seller may not sell, transfer,
pledge, hedge or otherwise dispose of them until the later of 12 months after closing and final resolution of any then-pending notice
under the Purchase Agreement’s share reversal provisions, subject to limited Company-approved transfers that remain subject to the
restrictions. Shares sufficient to cover other unresolved, timely notified indemnification claims will remain in escrow after that period.
The Seller generally retains voting rights and ordinary cash dividends while the shares are held, except during a pending reversal dispute;
other distributions remain subject to the holding arrangements. Expiration of the lock-up does not terminate continuing surrender or repayment
obligations.
Related party review and closing conditions
The Acquisition is a related party transaction
because the Seller is the Company’s chairman, a director and, effective November 19, 2026, its Chief Executive Officer, and will
receive the Consideration Shares for his Little Vault equity. The Purchase Agreement requires the Company to act through an independent
and disinterested special committee in evaluating, negotiating and overseeing the transaction. The Seller must disclose his interests
and recuse himself from approval deliberations and votes, except to provide requested information. Enforcement decisions concerning the
Seller must be made by the special committee or another authorized independent and disinterested body.
Closing is subject to conditions that include
satisfactory due diligence; approval of the final transaction terms by the special committee and authorization of the issuance and closing
by the board with the Seller recused; a written financial fairness opinion from an independent financial adviser; stockholder approval
required by Nasdaq Rule 5635(a)(2) and other applicable rules; and approval by holders of a majority of the outstanding common shares
not owned, directly or indirectly, by the Seller, his affiliates or other persons with a material interest in the transaction. The stockholder-approval
condition may not be waived.
Other closing conditions include completion of
the pre-closing restructuring and the IP agreements described below; receipt of PCAOB-audited and required interim financial statements
and final disclosure schedules; satisfaction of applicable Nasdaq notification and listing requirements, including an initial listing
application if required; necessary governmental, regulatory and material third-party approvals; continued Nasdaq listing; absence of a
material adverse effect or a legal prohibition; and customary representation and covenant conditions. Any applicable CFIUS, data-security
or other mandatory clearance and waiting-period requirements must also be satisfied. Schedule A and the disclosure schedules may be completed
after signing but must be delivered at least ten business days before the anticipated closing date and accepted in writing by AIFA. Later
disclosures do not qualify signing-date representations, cure existing breaches or limit AIFA’s remedies unless AIFA expressly agrees
in writing.
Closing is to occur on the third business day
after satisfaction or permitted waiver of the closing conditions, or on another date agreed in writing. The Company intends to seek the
required stockholder approvals. The anticipated timing for filing proxy or information materials, obtaining stockholder approvals and
closing is the first half of 2027. There can be no assurance that the conditions will be satisfied or that the Acquisition will be completed.
IP agreements and revenue protections
Before closing, the Seller must, and must cause
Little Vault and their respective affiliates to, complete a restructuring in compliance with applicable law and in a manner satisfactory
to AIFA, so that Little Vault validly holds, directly or through lawful indirect arrangements approved by AIFA in writing, (i) all rights,
interests and economic benefits relating to the Seller’s personal IP, including commercialization rights, revenue and receivables,
and (ii) the cooperation agreements with the other key personal IP partners and all related rights, interests, revenue and economic benefits
under those agreements. The restructuring also encompasses other material personal IP partner agreements and related operating assets.
It must be implemented through valid and enforceable written assignments, novations, transfers, licenses, consents or other lawful arrangements
approved by AIFA in writing, securing exclusive commercialization and revenue-collection rights free of encumbrances and conflicting rights.
Transferable ownership rights in the Seller’s personal IP must be assigned to Little Vault unless AIFA approves an alternative in
writing. Any indirect arrangement must give Little Vault effective control and direct contractual enforcement rights against the relevant
rights holders and intermediaries, enabling it to collect revenue and enforce rights in its own name without further consent or cooperation
from the Seller or his affiliates. Rights that cannot lawfully be transferred, including non-transferable personality or moral rights,
must be addressed through lawful exclusive commercialization permissions with a defined scope and term approved by AIFA and arrangements
securing the related economic benefits for Little Vault, subject to mandatory law. Completion is a pre-closing obligation of the Seller
and a condition to closing, and the Seller must deliver evidence and documents reasonably satisfactory to AIFA. The Seller must personally
enter into an IP cooperation agreement with Little Vault covering all his personal IP, and binding agreements with the other key personal
IP partners and the required consents, payment directions and account-control arrangements must be effective and operational by closing.
The Purchase Agreement requires Little Vault to
be the sole beneficiary of the covered IP commercialization and revenue rights before closing, whether held directly or through lawful
indirect arrangements satisfactory to AIFA. Little Vault must receive the sole and exclusive worldwide entitlement to all present and
future direct and indirect revenue and commercial or economic benefits from the Seller’s personal IP, including IP created or acquired
after closing, without any reserved entitlement for the Seller or his affiliates. The IP cooperation agreement must grant exclusive, worldwide,
sublicensable commercialization rights, permit lawful transfers within AIFA’s wholly owned group without further consent or payment
to the Seller, and provide that no royalty or other payment is payable to the Seller or his affiliates beyond the Consideration Shares.
It may not be terminated by the Seller or lapse because his service to AIFA ends, subject to the reversal provisions. For each other key
personal IP partner, the covered rights, revenue and economic benefits are limited to those arising under or within the scope of the applicable
cooperation agreement, as amended in accordance with the Purchase Agreement. AIFA must approve each such agreement in writing before closing,
including its scope, term, termination rights and exclusions; each must cover existing and future exploitation of the covered IP across
channels and platforms and prohibit diversion through new entities or arrangements. From closing, all direct and indirect revenue, income,
receipts and economic benefits within the applicable scope must belong to and be collected by the Company or a wholly owned subsidiary.
Little Vault will initially retain the rights and collection arrangements; subsequent transfers within the Company’s wholly owned
group must comply with applicable law and required consents. Diversion or retention of covered revenue outside that group is prohibited.
The provisions also impose IP, platform, legal-compliance, reporting, recordkeeping and inspection obligations, and the Seller is responsible
for procuring the required partner compliance on the terms of the Purchase Agreement.
The Purchase Agreement also contains noncompetition,
nonsolicitation and continued-service covenants applicable to the Seller and, where specified, his controlled affiliates. These apply
from signing until the later of three years after closing and one year after the Seller ceases to serve as a director, officer or employee
of AIFA or its subsidiaries, subject to stated exceptions and prospective cessation upon Reversal Completion. They expressly prohibit
commercialization of the Seller’s personal IP outside Little Vault or AIFA’s wholly owned group as permitted by the agreement.
Expiration of that restricted period or cessation of the Seller’s service does not release the separate exclusivity, non-diversion
and revenue obligations, subject to the reversal provisions and mandatory law.
Remedies and termination
Upon a breach of a fundamental representation
or a specified IP-related obligation, including prohibited revenue diversion, for which the Seller is responsible under the Purchase Agreement,
the Company may elect, through its independent decision-making body, to require surrender and cancellation of all Consideration Shares
and concurrently return all equity of Little Vault to the Seller. This remedy is not proportional to the amount of loss and is not conditioned
on a minimum breach amount, materiality threshold, prior opportunity to cure or quantified monetary loss. Only AIFA may elect the reversal;
the Seller has no right to initiate it. The Company may instead retain Little Vault and pursue other available remedies. The reciprocal
transfers are subject to notice, dispute-resolution, concurrent-performance and applicable-law requirements; a disputed allegation does
not itself cancel shares. If shares cannot lawfully be returned, the agreement requires a cash substitute for the unavailable shares at
the greater of the adjusted reference price and the 20-trading-day volume-weighted average price ending on the trading day before the
exchange is due, with the reference price applying if no reliable quotation exists.
In addition to a reversal, the Seller remains
responsible for remitting outstanding covered IP revenue and compensating recoverable losses, subject to the agreement’s monetary
limitations and prohibition on duplicate recovery. Return of Little Vault also requires repayment of post-closing funding provided by
the Company’s group and distributions received on the Consideration Shares. Upon legal completion of both reciprocal equity transfers
(“Reversal Completion”), future revenue-allocation obligations to the Company’s group cease prospectively, and the
acquired IP rights and related assets transferred within that group must be returned as provided in the agreement. Accrued claims and
related obligations survive.
The parties provide representations, warranties
and indemnities with survival periods, thresholds, caps and exceptions. General representation claims are generally subject to an 18-month
survival period, a $25,000 individual-claim threshold, a deductible basket equal to 1% of the purchase price and a 15% purchase-price
cap. Fundamental representations, which include representations concerning organization, authority and enforceability, capitalization
and title, brokers, sanctions, the Seller’s interested-director disclosures, the Seller’s personal IP ownership and control
and the absence of conflicting grants, the IP cooperation agreement, data privacy and cybersecurity, and the closing IP rights and revenue
entitlements, survive for six years after closing, and tax representations survive until 60 days after the applicable limitation period
expires; liability for those claims is capped at the purchase price. Monetary compensation for IP protection claims is generally capped
at the purchase price, while required remittance of covered revenue is uncapped; fraud and willful-misconduct exceptions apply. Ordinary
claims against the Seller are generally recoverable only from the Consideration Shares and specified related proceeds, with broader recourse
for excluded claims. The full-share reversal remedy is separate from the monetary compensation cap.
Before closing, the Company may terminate the
Purchase Agreement in its sole discretion at any time by written notice, without liability solely for exercising that right. Other termination
rights include mutual written agreement, failure to close by December 31, 2027 (unless the terminating party’s material breach primarily
caused the failure), specified uncured or incurable material breaches, and a final legal prohibition. Accrued rights and specified surviving
obligations remain enforceable. The Purchase Agreement is governed by Delaware law and provides for disputes to be heard in the People’s
Court of Haidian District, Beijing, subject to mandatory jurisdictional rules and provisions for interim relief and enforcement.
The foregoing description is qualified in its
entirety by the Purchase Agreement, which is filed as Exhibit 2.1 to this Current Report on Form 8-K and incorporated herein by reference.
Its representations, warranties and covenants were made for the parties’ benefit and may be subject to qualifications and limitations,
including disclosure schedules and negotiated risk allocations. They should not be read as statements of the current condition of the
Company or Little Vault separate from the other disclosures in this report and the Company’s SEC filings.
Item 3.02 Unregistered Sales of Equity Securities.
The information in Item 1.01 relating to the
Consideration Shares is incorporated herein by reference. Under the Purchase Agreement entered into on November 18, 2026, the Company
agreed to issue 1,280,000 shares of common stock to the Seller at closing, subject to the agreement’s conditions and recapitalization
adjustments, in exchange for all outstanding equity of Little Vault. The agreed value of this noncash consideration is $8 million, or
$6.25 per share. The Company will receive Little Vault equity rather than cash proceeds from this issuance. No Consideration Shares have
been issued as of the date of this report.
The offer and sale of the Consideration
Shares have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), and are being made
in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D
promulgated thereunder. The transaction is privately negotiated with the Seller, an existing director and chairman and, effective
November 19, 2026, the Chief Executive Officer of the Company. The Seller has represented that he is acquiring the shares for his
own investment account and not with a present view to an unlawful distribution, has sufficient financial and business knowledge to
evaluate the investment, and has had access to the Company’s SEC filings and an opportunity to ask questions. The shares will
be subject to restrictions on transfer under applicable securities laws and the Purchase Agreement. The Company has agreed to pay
financial advisory fees in connection with the Acquisition, subject to the terms of the applicable engagement arrangements.
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective November 19, 2026, Weizhi (Eric) Shao
ceased to serve as the Company’s Chief Executive Officer and departed the Company. The Board of Directors appointed Li Shanglong
(also known as Shanglong Li) as the Company’s Chief Executive Officer, effective on the same date. Li Shanglong will continue to
serve as Chairman of the Board and a director. As a result of his appointment as an executive officer, Li Shanglong no longer qualifies
as an independent director under the Nasdaq listing standards.
Li Shanglong has served as Chairman of the Board
and a director since June 17, 2026. The biographical information concerning Li Shanglong under “CURRENT DIRECTORS, DIRECTOR NOMINEES
AND EXECUTIVE OFFICERS” in the Company’s definitive proxy statement dated September 14, 2026 is incorporated herein by reference.
The description in Item 1.01 of the Purchase Agreement and Li Shanglong’s interest in the Acquisition is also incorporated into
this Item 5.02 by reference.
The Company and Li Shanglong have agreed to employment
terms set out in an employment agreement (the “Employment Agreement”) providing for a term from November 19, 2026 through
November 18, 2028, unless terminated earlier. Li Shanglong will report to the Board and devote his full working time to the Company. The
Company will use commercially reasonable efforts to secure Li Shanglong’s election as a director throughout his employment, including
nomination when his Board term would otherwise expire.
The Employment Agreement provides for an annual
base salary of $300,000 during the term, subject to applicable withholdings. Thereafter, salary is subject to applicable company-wide
cost-of-living adjustments and other adjustments by the Board. As of November 19, 2026, the Company has not granted Li Shanglong any restricted
stock awards or stock options, and the Employment Agreement does not grant any new equity awards. Future grants are discretionary, require
Board or authorized committee approval and available shares under the Company’s 2019 Equity Incentive Plan, as amended, and are
governed by that plan and separate written award agreements. Future restricted-stock grants also depend on individual performance and
the Company’s financial performance. Li Shanglong is entitled to four weeks of paid vacation annually, subject to the agreement’s
accrual limits, reasonable business-expense reimbursement and executive employee benefits.
The Company may terminate Li Shanglong’s
employment with or without cause, and Li Shanglong may resign, including for good reason as defined in the Employment Agreement. A Company
decision not to extend the term is treated as termination without cause. Upon termination, including death or disability, the Employment
Agreement provides for payment of earned and unpaid base salary and accrued, unused vacation. It does not provide additional cash severance
or automatic acceleration of equity awards; rights relating to any future equity awards will be governed by the applicable plan and written
award agreements.
The Employment Agreement also provides for indemnification
and advancement of expenses, subject to its conditions, and D&O and other specified insurance coverage during employment and for at
least five years thereafter. It includes continuing confidentiality obligations, subject to protected reporting and other legal rights,
and a Section 280G limitation reducing covered parachute payments, if applicable, to no more than 2.99 times the statutory base amount.
The Employment Agreement is governed by Nevada law and provides for venue in the federal or state courts in Nevada.
Except as described in this report, there are
no arrangements or understandings between Li Shanglong and any other person pursuant to which he was appointed Chief Executive Officer,
no family relationships between Li Shanglong and any director or executive officer of the Company, and no other transactions involving
Li Shanglong requiring disclosure under Item 404(a) of Regulation S-K.
Forward Looking Statements
This report contains forward-looking statements
concerning the proposed Acquisition, the issuance of Consideration Shares, required approvals, closing conditions and timing, and future
IP and revenue arrangements. These statements are based on current expectations and are subject to risks and uncertainties, including
failure to obtain required stockholder, Nasdaq or regulatory approvals or a satisfactory fairness opinion, failure to complete the restructuring
or secure enforceable IP rights, delays or inability to satisfy closing conditions, termination of the Purchase Agreement, disputes over
revenue collection or enforcement, the enforceability of the share reversal remedy and of judgments obtained in the People’s Republic
of China, and the risks described in the Company’s SEC filings. Actual outcomes may differ materially. The Company undertakes no
obligation to update forward-looking statements except as required by law.
Additional Information and Where to Find It
This report does not constitute a solicitation
of any vote or approval. In connection with the proposed Acquisition, the Company intends to file with the SEC a proxy statement or an
information statement, as applicable, and other relevant materials. STOCKHOLDERS ARE URGED TO READ THOSE MATERIALS CAREFULLY AND IN THEIR
ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE ACQUISITION. Stockholders may obtain free
copies of these materials, when available, at the SEC’s website at www.sec.gov. The Company and its directors and executive officers,
including the Seller, may be deemed participants in the solicitation of proxies in connection with the Acquisition. Information about
the Company’s directors and executive officers is available in its definitive proxy statement dated September 14, 2026 and subsequent
SEC filings. Additional information about their interests in the Acquisition, including the Seller’s interests described in this
report, will be included in the proxy statement or the information statement, as applicable, when filed.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit
No. |
|
Description |
| 2.1* |
|
Stock Purchase Agreement, dated November 18, 2026, by and among All In FutureTech Alliance, Inc., Li Shanglong and Little Vault Inc. |
10.1† |
|
Employment Agreement, dated as of November 19, 2026, by and between All In FutureTech Alliance, Inc. and Li Shanglong. |
| 104 |
|
Cover Page Interactive
Data File (embedded within the Inline XBRL document). |
| * | Certain schedules have been omitted pursuant to Item 601(a)(5)
of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule to the SEC upon request. |
| † | Indicates a management contract or compensatory plan or arrangement. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
ALL IN FUTURETECH ALLIANCE, INC. |
| |
|
| |
By: |
/s/
Roy Anderson |
| |
|
Roy Anderson |
| |
|
Chief Financial Officer |
Date: November 19, 2026